ATOSSA THERAPEUTICS, INC. Increase (Decrease) in Other Operating Assets
ATOSSA THERAPEUTICS, INC. (ATOS) reported Increase (Decrease) in Other Operating Assets of $4.46 thousand for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2015-11-12
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2015-09-30 was $2.00, a 99.99% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2015-06-30 was -$123.91K.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2015-03-31 was $128.36K, a 416.27% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2014-09-30 was $17.65K.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 9 month |
|---|---|---|---|
| 2015-09-30 | $2.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$123.90K derived: sum of 2 quarters · filed 2015-11-12 | $4.46K 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$123.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $4.45K 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $128.36K 10-Q · filed 2015-05-13 | ||
| 2014-09-30 | $17.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $17.65K derived: sum of 2 quarters · filed 2015-11-12 | $42.51K 10-Q · filed 2015-11-12 |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $24.86K 10-Q · filed 2015-08-06 | |
| 2014-03-31 | $24.86K 10-Q · filed 2015-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |